Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2007-03-06
2007-03-06
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S180000, C552S570000, C552S574000
Reexamination Certificate
active
11028198
ABSTRACT:
Steroidal compounds or their salts having general formula:in-line-formulae description="In-line Formulae" end="lead"?A—B—C—NO2in-line-formulae description="In-line Formulae" end="tail"?are described, wherein:A=R—, wherein R is a steroidal drug radical;B=—TB—X2—TBI—, wherein TBis (CO), TBIis O, S, NH, and X2is a bivalent bridging group; andC is a bivalent radical.
REFERENCES:
patent: 3702335 (1972-11-01), Lafill
patent: 3963707 (1976-06-01), Högberg et al.
patent: 4913852 (1990-04-01), Milioni et al.
patent: 4956384 (1990-09-01), Chiesi et al.
patent: 5318987 (1994-06-01), Weithmann et al.
patent: 5508275 (1996-04-01), Weithmann et al.
patent: 5707984 (1998-01-01), Tjoeng et al.
patent: 5837698 (1998-11-01), Tjoeng et al.
patent: 19634793 (1998-03-01), None
patent: 0 549 318 (1993-06-01), None
patent: 0 562 497 (1993-09-01), None
patent: 0 578 494 (1994-01-01), None
patent: 58-045724 (1983-03-01), None
patent: 4-273892 (1992-09-01), None
patent: 5-39261 (1993-02-01), None
patent: WO 98/15568 (1998-04-01), None
International Search Report; Nov. 21, 2000.
Hungarian Novelty Search Report; Mar. 23, 2004.
Cederqvist et al.,Biochem. Pharmacol.47(6), 1047-1053, 1994.
Bonn et al.,Cardiovasc. Drug Rev.16(3), 195-211, 1998.
K. B. Schwarz, “Oxodative Stress During Viral Infection: A Review”, Free Radical Biology & Medicine, vol. 21, No. 5, 1996, pp. 641-649.
Goodman & Gillman, “The Pharmacological Basis of Therapeutics”, 9thEdition, 1996, McGraw-Hill Health Preffsions Division, pp. 1459-1465 and 1474.
Martindale, The Extraphamacopeia, 30thEdition, 1993, pp. 712-723.
Nenseter et al, “Paracetamol nhibits Copper Ion-Induced, Azo Compound-Initialed, and Mononuclear Cell-Mediated Oxidative Modification of LDL”, Arterioscierosis, Thombosis, and Vascular Biology, vol. 15, No. 9, Sep. 1995, pp. 1338-1344.
Baylis et al, “Chronic Blockade of Nitric Oxide Synthesis in the Rat Produces Syntemic Hypertension and Glomemerular Damage”, J. Clin. Investigation, vol. 90, 1992, pp. 279-281.
Arent & Fox PLLC
Badio Barbara P.
Nicox S.A.
LandOfFree
Steroidal compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Steroidal compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroidal compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3725970